Month: May 2024

ATHENS, Greece, May 07, 2024 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced today that it will hold a conference call to discuss the Company’s results for the first quarter 2024 on Thursday, May 16, 2024 at 10:30 a.m. Eastern Time. The Company will issue financial results for the first quarter 2024 on Thursday, May 16, 2024, before the open of market trading.What: First Quarter 2024 Conference Call and Webcast   When: Thursday, May 16, 2024 at 10:30 a.m. Eastern Time   Where: There are two ways to access the conference call:     Dial-in: (646) 307-1963 or (800) 715-9871; Event ID: 1926153Please dial in at least 10 minutes prior to 10:30 a.m. Eastern Time to ensure a prompt start to the call.     Live Internet webcast and slide presentation:http://www.globalshiplease.com   The...

Company to host conference call to discuss financial results and provide a corporate update on May 13, 2024 at 4:30 p.m. ET SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its first quarter 2024 financial results after the U.S. financial markets close on Monday, May 13, 2024. Journey Medical management will conduct a conference call and audio webcast on Monday, May 13, 2024 at 4:30 p.m. ET. To listen to the conference call, interested parties within the U.S. should dial 1-866-777-2509 (domestic) or 1-412-317-5413 (international)....

WOBURN, Mass., May 07, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology, announces its strategic partnership with Be A Part Of, an award-winning ecommerce agency. This collaboration between Bridgeline’s site search product, HawkSearch, and Be a Part Of signals a significant advancement in revolutionizing ecommerce search experiences for brands worldwide. Be A Part Of leverages HawkSearch’s state-of-the-art capabilities in ecommerce search, product discovery, and recommendations to enhance online shopping journeys for its client roster of global brands, wholesalers, and retailers. By integrating HawkSearch’s technology, Be A Part Of aims to empower brands to elevate engagement, drive conversions, and maximize revenue across their digital platforms. Ari...

Earnings Webinar Scheduled For 1:00 p.m. ET, May 9, 2024 CALGARY, Alberta, May 07, 2024 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“), a North American leading manufacturer and supplier of technologically advanced cellular concrete products, today announced that it will release its consolidated financial results for the first quarter ending March 31, 2024, after the market closes on May 8, 2024. Management will host a webinar at 1:00 p.m. ET on Thursday, May 9, 2024, to discuss CEMATRIX’s first quarter financial results, provide a corporate update and conclude with a question-and-answer session from online participants. To participate, please use the following information: You are invited to a Zoom webinar.When: May 9, 2024 11:00 AM Mountain Time (US and...

SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced its support of new guidelines released by the U.S. Preventive Services Task Force (USPSTF) recommending that women begin breast cancer screening starting at age 40. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer. The updated guidelines recommend women undergo biennial mammography screening beginning at the age of 40 until the age of 74. The change to the recommended age comes in response to rising breast cancer rates among younger women and racial disparities in breast cancer diagnosis and mortality. The announced changes from USPSTF also come in advance of a September 2024 deadline...

Barfresh Secures 443 New School Customer Locations Across Multiple States, Serving Barfresh Products to Over 360,000 Students Customer Growth Acceleration Fuels Company’s Projected Record Fiscal Year 2024 Revenue and Year Over Year Margin Expansion LOS ANGELES, May 07, 2024 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, reinforced its education channel sales momentum today by announcing new multi-state customer wins, broadening its reach in this key market. The Company recently secured 443 new school locations, representing a collective population of over 360,000 students. These new school locations plan to introduce a varied selection of the Company’s products, including its Twist & Go carton and bottled smoothie...

SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), “), a global leader in safe and high-performance energy storage solutions, today announced the Company has successfully completed large format fractional thermal runaway calorimeter (“L-FTRC”) tests for 200 Amp-hour (Ah) high energy Nickel Manganese Cobalt (NMC) prismatic format lithium-ion cells for its global automotive OEM customer. As the exclusive licensee of the L-FTRC technology from NASA, KULR is uniquely positioned to service customers in electric vehicles, grid energy storage and industrial applications with L-FTRC testing of their batteries in the global cell testing market estimated to reach USD $7 billion by 2030. Just last year, a leading global automaker selected KULR...

Biopharma industry veteran joins Scorpius’ leadership team DURHAM, N.C., May 07, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced the appointment of Shari Udoff-McDonald as VP of Business Development. She brings more than 25 years of experience in biopharma business development and management. Prior to joining Scorpius, Ms. Udoff-McDonald spent 17 years at BioReliance Corporation, part of MilliporeSigma. She was most recently Head of Commercial, North America, East with interim oversight of half of the European market. Her role included commercial oversight of biologics, vaccines, cell and gene therapies, ADCs, and mRNA GMP testing services for sponsors and CDMOs. Joe Payne, Scorpius’ President...